Cargando…
ESR1 PvuII polymorphism: from risk factor to prognostic and predictive factor of the success of primary systemic therapy in advanced breast cancer
BACKGROUND: The ESR1 gene encodes Estrogen Receptor alpha (ERα), which plays a role in the tumourigenesis of breast cancer. A single nucleotide polymorphism (SNP) in intron 1 of this gene called ESR1 PvuII (rs2234693) has been reported to increase the risk of breast cancer. This study aimed to inves...
Autores principales: | Karsono, Ramadhan, Haryono, Samuel J., Karsono, Bambang, Harahap, Wirsma Arif, Pratiwi, Yulia, Aryandono, Teguh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686387/ https://www.ncbi.nlm.nih.gov/pubmed/34930150 http://dx.doi.org/10.1186/s12885-021-09083-x |
Ejemplares similares
-
Effect of Primary Systemic Therapy on PD-1, PD-L1, and PD-L2 mRNA Expression in Advanced Breast Cancer
por: Karsono, Ramadhan, et al.
Publicado: (2021) -
Polymorphism of PvuII, Xba1, and SNP 12 Estrogen Receptor 1 (ESR1) in Hipospadias Patients at Tertiary Hospital Center
por: Siregar, Safendra, et al.
Publicado: (2021) -
ESR1 PvuII (rs2234693 T>C) polymorphism and cancer susceptibility: Evidence from 80 studies
por: Liu, Xiaoqi, et al.
Publicado: (2018) -
The variant T allele of PvuII in ESR1 gene is a prognostic marker in early breast cancer survival
por: Houtsma, Danny, et al.
Publicado: (2021) -
PvuII polymorphism of estrogen receptor-α gene in breast cancer
por: Surekha, D., et al.
Publicado: (2007)